Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2021 Dec 23;226(1):S582–S583. doi: 10.1016/j.ajog.2021.11.963

Mode of Delivery in Patients with COVID-19

Matthew Miyamoto 1, Elsa Perreand 1, Mary Mangione 1, Mayuri Patel 2, Liviu Cojocaru 2, Hyunuk Seung 3, Joel Chua 1, Ozhan M Turan 4, Shifa Turan 2
PMCID: PMC8696705

Objective

Previous studies have suggested that coronavirus infectious disease 2019 (COVID-19) during pregnancy increases the rate of cesarean delivery (CD). We aimed to evaluate the mode of delivery (MOD) in patients with COVID-19 compared with negative controls, after adjusting for age, race/ethnicity, body mass index, and past medical history.

Study Design

We conducted a retrospective, multicenter case-control study to understand the association between COVID-19 in pregnancy and neonatal outcomes. We reviewed consecutive charts of adult females, ages 18-45, with laboratory-confirmed SARS-CoV-2 infection in six months between March 1, 2020, and August 31, 2020. Cases were patients diagnosed with COVID-19 during pregnancy [COVID (+)], whereas controls were pregnant patients who tested negative for COVID-19 [COVID (-)]. We excluded early pregnancy losses, termination of pregnancies, cases with multiple gestation or incomplete data. For cases delivered via CD, we reviewed if the delivery indication was COVID-19 related or not. We employed PSM to lessen the potential influence of confounding factors and increase the reliability of the results. The PSM was performed using age, race/ethnicity, body mass index, and past medical history (hypertension, cardiac disease, asthma, DM, venous thromboembolism). Analyses were performed with SAS software.

Results

A total of 2474 patients were identified, of which 2374 were COVID (-) and 100 COVID (+). After the PSM algorithm was applied, 388 patients remained in COVID (-) group and 97 in the COVID (+) group. Vaginal delivery was similar between COVID (+) and COVID (-) groups [ 68 (70.1%) vs 271(69.8%), p=1.0]. Further, there was no difference in rate of CD between COVID (+) and COVID (-) groups [29 (29.90%) vs 117 (30.15%), p = 1.0], nor significant increase in COVID related CD [3 (10.3%), p = 1.0].

Conclusion

Our results suggest that COVID-19 during pregnancy does not increase the rate of CD, contrary to previous reports. A potential explanation is that in our study the PSM reduced confounding factors that could have resulted otherwise in discrepancies of MOD.

914


Articles from American Journal of Obstetrics and Gynecology are provided here courtesy of Elsevier

RESOURCES